FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.24 | FHIR Version n/a User: [n/a]

481511000001109: ReQuip 250microgram tablets (GlaxoSmithKline) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\ReQuip 250microgram tablets (GlaxoSmithKline)
\UK product\Virtual medicinal product\Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet\ReQuip 250microgram tablets (GlaxoSmithKline)
\UK product\Virtual therapeutic moiety\Ropinirole\Product containing only ropinirole in oral dose form (medicinal product form)\Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet\ReQuip 250microgram tablets (GlaxoSmithKline)
\UK product\Virtual therapeutic moiety\Ropinirole\Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet\ReQuip 250microgram tablets (GlaxoSmithKline)
\UK product\Trade family\ReQuip\ReQuip 250microgram tablets (GlaxoSmithKline)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16961901000001116 ReQuip 250microgram tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

58163801000001110 ReQuip 250microgram tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
ReQuip 250microgram tablets (GlaxoSmithKline)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Is a	Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has active ingredient	Ropinirole hydrochloride	false	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has active ingredient	Ropinirole	false	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Is a	ReQuip	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Ropinirole	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has specific active ingredient	Ropinirole hydrochloride	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline)	Has basis of strength substance	Ropinirole	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet	Is pack of	False	ReQuip 250microgram tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 42 tablet	Is pack of	False	ReQuip 250microgram tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 42 tablet	Has AMP	True	ReQuip 250microgram tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline) 210 tablet	Has AMP	True	ReQuip 250microgram tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
ReQuip 250microgram tablets (GlaxoSmithKline UK Ltd) 21 tablet	Has AMP	True	ReQuip 250microgram tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16961901000001116	ReQuip 250microgram tablets (GlaxoSmithKline) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
58163801000001110	ReQuip 250microgram tablets (GlaxoSmithKline UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module